That is not a call we make. What we can tell you is that the evidence supporting them in this application is much weaker than the confidence of the marketing, and that any product interacting with absorption deserves a conversation with a clinician or pharmacist first.

Is there a test that shows whether this applies to me?

No, and that is the load-bearing gap. There is no accepted way to establish that a biofilm is responsible for your symptoms, which means the explanation can be neither confirmed nor ruled out in an individual. An account that cannot be checked in either direction is a difficult thing to spend money on, whatever its plausibility.

My treatment did not work. Does that point here?

Not by itself. Treatment failure is common in this area and has several ordinary explanations, including that the original target was wrong, that the test used to select it is disputed, or that the problem simply recurred. Any of those produces the same experience. An explanation that fits your outcome is not the same as one shown to have caused it.

Biofilms

By BeatSIBO editorial team · Updated August 5, 2026

This is the widest gap on the site between how much something is discussed and how much is actually established about it in people.

What a biofilm is

The short answer

A community of microorganisms living within a matrix they produce themselves, which behaves differently from the same organisms floating freely. This is well established microbiology and is not in dispute. Biofilms matter in dentistry, in wound care and on medical devices, where they have been studied directly.

None of that is controversial. The controversy starts when the concept is carried across into gut conditions and turned into a product category. Only the prescription antibiotic and the low-FODMAP approach get discussed more than this does, which is a great deal of attention for a topic with, as far as we can find, very little direct human evidence in this specific application.

Why the gap exists

The short answer

Biofilms offer an explanation for treatment failure, and treatment failure is a common and demoralising experience in this area. An idea that explains why something did not work is compelling regardless of how well supported it is, and that is precisely the kind of idea that sells products.

We want to be fair here. The reasoning is not stupid. If organisms in a matrix are harder to reach, then a treatment that fails might have failed for that reason. That is a legitimate hypothesis. It is just not the same as a demonstrated mechanism in this context with a product shown to change an outcome.

What is not settled here

We could not find human trial evidence supporting marketed biofilm disruptors for gut conditions at a standard we would report as established. That is a statement about what we found, not proof that none exists, and we would genuinely like to be sent any we missed. What we can say is that the confidence of the marketing in this category is not proportional to anything we located.

What the surrounding evidence looks like

Pimentel M et al., American Journal of Gastroenterology 2020 Clinical guideline

For context on the standard being applied: the clinical guideline covering the condition these products are aimed at rates five of its six recommendations as resting on very low quality evidence. Biofilm protocols are not in that guideline at all.

What this page will not do

No protocol, no dosing, no product ranking. Products in this category typically contain enzymes, chelating agents or plant extracts in combinations that vary completely between brands, with no standard formulation and no agreed outcome measure. Ranking them would imply a basis for comparison that does not exist.

If you are considering something in this category, the practical point worth raising with a clinician or pharmacist is interaction: products that affect absorption can affect the absorption of things you need.

Common questions

Should I avoid them?: That is not a call we make. What we can tell you is that the evidence supporting them in this application is much weaker than the confidence of the marketing, and that any product interacting with absorption deserves a conversation with a clinician or pharmacist first.
Is there a test that shows whether this applies to me?: No, and that is the load-bearing gap. There is no accepted way to establish that a biofilm is responsible for your symptoms, which means the explanation can be neither confirmed nor ruled out in an individual. An account that cannot be checked in either direction is a difficult thing to spend money on, whatever its plausibility.
My treatment did not work. Does that point here?: Not by itself. Treatment failure is common in this area and has several ordinary explanations, including that the original target was wrong, that the test used to select it is disputed, or that the problem simply recurred. Any of those produces the same experience. An explanation that fits your outcome is not the same as one shown to have caused it.